Etomidate to Improve Outcome in Elderly Patients

NACompletedINTERVENTIONAL

Enrollment

1,917

Participants

Timeline

Start Date

August 15, 2017

Primary Completion Date

November 20, 2019

Study Completion Date

November 20, 2020

Conditions

Postoperative Complications

Interventions

DRUG

Etomidate

etomidate is given intravenously

DRUG

propofol

propofol is given intravenously

DRUG

Sufentanil

sufentanil is given intravenously

DRUG

Cisatracurium

Cisatracurium is given intravenously

Trial Locations (1)

Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors

lead

Zhihong LU

OTHER

NCT02910206 - Etomidate to Improve Outcome in Elderly Patients | Biotech Hunter | Biotech Hunter